Search Results Search Sort by RelevanceMost Recent In the Literature Jan 2007 Connecting Inadequate Health Insurance to Poorer Cancer Treatment Outcomes Allison Grady Virtual Mentor. 2007;9(1):26-29. doi: 10.1001/virtualmentor.2007.9.1.jdsc1-0701. In the Literature Aug 2016 Error Disclosure in Pathology and Laboratory Medicine: A Review of the Literature Ifeoma U. Perkins, MD A neglected topic in medical ethics is the unique barriers to error disclosure faced by anatomic and clinical pathologists. AMA J Ethics. 2016;18(8):809-816. doi: 10.1001/journalofethics.2016.18.8.nlit1-1608. In the Literature Jun 2002 Disparities in Cancer Survival between Blacks and Whites Faith Lagay, PhD and Rita Mitchell Virtual Mentor. 2002;4(6):171-172. doi: 10.1001/virtualmentor.2002.4.6.jdsc1-0206. In the Literature Dec 2010 Evidence-Based Medicine: Can You Trust the Evidence? Yvonne M. Buys, MD In reports of industry-funded studies that compared the ocular hypotensive efficacy of topical prostaglandins, conclusions in the article abstracts differed from the results of the main outcome measure 62 percent of the time. Virtual Mentor. 2010;12(12):930-933. doi: 10.1001/virtualmentor.2010.12.12.jdsc1-1012.
In the Literature Jan 2007 Connecting Inadequate Health Insurance to Poorer Cancer Treatment Outcomes Allison Grady Virtual Mentor. 2007;9(1):26-29. doi: 10.1001/virtualmentor.2007.9.1.jdsc1-0701.
In the Literature Aug 2016 Error Disclosure in Pathology and Laboratory Medicine: A Review of the Literature Ifeoma U. Perkins, MD A neglected topic in medical ethics is the unique barriers to error disclosure faced by anatomic and clinical pathologists. AMA J Ethics. 2016;18(8):809-816. doi: 10.1001/journalofethics.2016.18.8.nlit1-1608.
In the Literature Jun 2002 Disparities in Cancer Survival between Blacks and Whites Faith Lagay, PhD and Rita Mitchell Virtual Mentor. 2002;4(6):171-172. doi: 10.1001/virtualmentor.2002.4.6.jdsc1-0206.
In the Literature Dec 2010 Evidence-Based Medicine: Can You Trust the Evidence? Yvonne M. Buys, MD In reports of industry-funded studies that compared the ocular hypotensive efficacy of topical prostaglandins, conclusions in the article abstracts differed from the results of the main outcome measure 62 percent of the time. Virtual Mentor. 2010;12(12):930-933. doi: 10.1001/virtualmentor.2010.12.12.jdsc1-1012.